Rubicon Research Secures ₹619 Crore from Anchor Investors Before IPO Launch
Rubicon Research, a Mumbai-based pharmaceutical company, has secured ₹619 crore from anchor investors ahead of its public issue. The strong anchor round signals institutional trust in the company’s model, its export focus, and its R&D pipeline. According to reports from authentic sources, the public offer opens this week, and proceeds will target debt repayment, R&D…